CP Reports
CP Insight
Current Agreements
CP Knowledge Centre
CP Consulting

New report

Provides comprehensive understanding and unprecedented access to the  clinical stage partnering agreements deals and agreements entered into by the worlds leading healthcare companies. More

 

Featured partnering deals

Janssen signs a biotech deal with Ruijin Hospital

October 29, 2014 : big biotech, big pharma, Janssen

Janssen Pharma signed a biotech deal to collaborate on translational research with Shanghai Ruijin Hospital, which opened a Translational Medicine Center in early October. more »

Iroko signs pharma licensing deal with Aspen

October 29, 2014 : Aspen, big pharma, pharma licensing

Iroko Pharmaceuticals signed a licensing agreement with Aspen Pharma for the exclusive rights to register and market ZORVOLEX (diclofenac) capsules in Australia and New Zealand. more »

 More partnering deals | all deals at Deal Monitor


Featured M&A deals

Wright has acquired Tornier for $3.3 billion

October 29, 2014 : acquisition, M&A, medical device

Wright Medical Group and Tornier have entered into a acquired agreement under which Wright and Tornier will combine in an all stock transaction with a combined equity value of approximately $3.3 billion. more »

BMS and F-Star Alpha agree on acquisition of lead compound

October 29, 2014 : acquisition, asset purchase, Bristol-Myers Squibb

Bristol-Myers Squibb has entered a deal with F-star Alpha that gives it the option for acquisition and gain rights to its lead asset, FS201. more »

 More M&A deals | all deals at Deal Monitor

Featured financing deals

Syros has raised $53 million in Series B financing

October 28, 2014 : financing, financings

Syros Pharmaceuticals has ended a Series B round of financing, totalling around $53 million. more »

Pfizer approves share repurchase of $11 billion

October 27, 2014 : big pharma, financing, Pfizer

Pfizer approved the share repurchase of $11 billion in company stock. more »

 More financing deals | all deals at Deal Monitor

Latest Dealtalk

Equity firms eye Bayer’s plastic business merger

October 27, 2014 : Bayer, big pharma, business merger

Private equity firms are circling Bayer’s €10bn plastics business merger, hoping to divert the German drugmaker from its plan to list the division, two people familiar with the matter said yesterday. more »

Both, Actavis and Sanofi competing for Omega Pharma

October 22, 2014 : Actavis, Sanofi

Several companies are rumored to be competing to acquire Omega Pharma, the fastest growing consumer healthcare company in the U.K. and Ireland. more »

 More dealtalk

Featured reports

Global Joint Venture Partnerships

Publication date: October 2014

Top 50 Big Pharma Partnering and M&A

Publication date: October 2014

Bioinformatics Partnering Terms and Agreements

Publication date: October 2014

Top 50 Big Biotech Partnering and M&A

Publication date: October 2014

Molecular Diagnostics Partnering Terms and Agreements

Publication date: October 2014

Regenerative Medicine Partnering Terms and Agreements

Publication date: October 2014

Discovery Stage Partnering Terms and Agreements

Publication date: September 2014

Preclinical Stage Partnering Terms and Agreements

Publication date: September 2014

Co-development Terms and Agreements

Publication date: August 2014

Personalized Medicine in Oncology Partnering Terms and Agreements

Publication date: August 2014

Licensing Terms and Agreements

Publication date: August 2014

Diagnostic Imaging Partnering Terms and Agreements

Publication date: August 2014

Trends in Therapeutic Partnering

Publication date: August 2014

Cancer Monoclonal Antibody Terms and Agreements

Publication date: August 2014

Monoclonal Antibody Terms and Agreements

Publication date: August 2014

Co-promotion & Co-marketing Partnering Terms and Agreements

Publication date: July 2014

Drug Delivery Terms and Agreements

Publication date: July 2014

NEW: Therapy deal reports covering all major indications

Including partnering in oncology, cardiovascular, CNS, metabolic, dermatology, dental, infectives, immunologypsychiatry, genitourinary.....plus many others

View all reports

Scorecard

Current Partnering provides access to key deal metrics for all leading partnering, M&A and financings - plus big pharma partnering activity and R&D spend metrics.

Available scorecards:

Partnering

M&A

Financing

Top 50 pharma partnering

Top 50 biotech partnering

Top pharma R&D spend

Deal metrics - by stage of development, therapy area, industry sector

Print Friendly
cpbannerad300x150new1gif
RSS Feed Linked In Twitter

Latest Tweets

cabannerad300x150new4gif
pharmavenue-datesjpg
beu14banner300x150jpg